Illustration: Eniola Odetunde/Axios
Permira acquired a majority stake in Israeli fraud detection company BioCatch, valuing the company at $1.3 billion.
Why it matters: The deal represents significant returns for investors including Bain Capital and Maverick in a slow exit market.